Carregant...
Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
Therapy for inflammatory bowel disease (IBD) has changed, with several new agents being evaluated. The era of anti-tumor necrosis factor (anti-TNF) antibody therapy saw remarkable progress in IBD therapy. Some patients, however, do not respond to anti-TNF treatment, or their response decreases over...
Guardat en:
| Publicat a: | Gut Liver |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Editorial Office of Gut and Liver
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491079/ https://ncbi.nlm.nih.gov/pubmed/28486793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16308 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|